Aids Weekly Plus
An article in Healio reported on a study of adolescents’ acceptance of expedited partner therapy (EPT) to treat a sexually transmitted infection (STI). In this study, Ana Radovic, MD, MSc, a fellow in the division of adolescent medicine at Children’s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, and colleagues investigated whether adolescents would use EPT if diagnosed with chlamydia. The 387 participants ages 13–22 completed a survey on the subject during July–August 2010. EPT was defined as giving a prescription to a partner exposed to chlamydia.
The survey included the hypothetical scenario suggesting that participants received a chlamydia diagnosis and had to choose among a number of methods for notifying and treating the partner. The methods were as follows: patient referral, in which the participant tells the partner; provider referral by a doctor, in which the doctor calls the partner; provider referral by the health department; EPT prescription, in which the doctor gives the participant the prescription for the partner; and EPT medicine, in which the doctor gives the participant the medicine for the partner.
A high percentage of participants (85 percent) responded that they would be likely or very likely to use the EPT prescription and EPT medicine options. Participants also favored patient referral, but were not partial to provider referral or health department referral. Results showed similar rates of EPT choice for males and females as well as for participants with no history of STI and those who were not sexually active.
The researchers suggested future research on actual use of EPT by age in clinical setting for adolescents diagnosed with STIs.
The full report, “Adolescents' Attitudes Toward Expedited Partner Therapy for Sexually Transmitted Infections,” was published in the journal Sexually Transmitted Diseases (2013; 40 (11):894-897; doi: 10.1097/OLQ.0000000000000034).